SCHEMBL4081074

SCHEMBL4081074

CCCCC(=O)Oc1cc(C)cc(O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.43
MEN1 O00255 2/20 0.41
KDM4E B2RXH2 1/20 0.41
RECQL P46063 1/20 0.41
MIF P14174 1/20 0.39
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
GAA P10253 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HSD17B3 P37058 1/20 0.38
ALOX15 P16050 1/20 0.38
NR4A1 P22736 1/20 0.37
PTGES O14684 1/20 0.37
TOP2A P11388 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9752590 0.90 KMT2A (0.45) KMT2ASMN1; SMN2MEN1KDM4ERECQL
SCHEMBL2849301 0.86 VCAM1 (0.44) KMT2AHPGDMEN1GAAALDH1A1
SCHEMBL15463445 0.85 KMT2A (0.48) KMT2ASMN1; SMN2CNR1CNR2ALOX15
SCHEMBL9776801 0.84 PTGS2 (0.51) KMT2ASMN1; SMN2MEN1KDM4ERECQL
SCHEMBL27261307 0.83 KMT2A (0.50) KMT2ASMN1; SMN2HPGDMEN1NPC1
SCHEMBL14060911 0.83 KMT2A (0.50) KMT2ASMN1; SMN2CNR1CNR2ALOX15
SCHEMBL22471815 0.83 KMT2A (0.50) KMT2ASMN1; SMN2CNR1CNR2ALOX15
SCHEMBL11546979 0.83 KMT2A (0.50) KMT2ASMN1; SMN2CNR1CNR2ALOX15
SCHEMBL14831865 0.83 KMT2A (0.50) KMT2ASMN1; SMN2CNR1CNR2ALOX15
SCHEMBL675476 0.83 KMT2A (0.50) KMT2ASMN1; SMN2CNR1CNR2ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7527809-B2 Polyhydroxyalkanoate-containing magnetic structure, and manufacturing method and use thereof CANON KABUSHIKI KAISHA (JP) 2009-05-05 US disclosed
US-7452960-B2 Polyhydroxyalkanoate copolymer, resin composition, molded product, toner, image forming method and image forming apparatus CANON KABUSHIKI KAISHA (JP) 2008-11-18 US disclosed
CN-100381940-C Polyhydroxyalkanoate containing amide group, sulfonic group, and sulfonate ester group, method for producing the same, and charge control agent, toner, image forming method, and image forming apparatu CANON KK (JP) 2008-04-16 CN disclosed
CN-100370365-C Novel polyhydroxyalkanoate having amide group, sulfonic group or sulfonate group, charge control agent and toner CANON KK (JP) 2008-02-20 CN disclosed
EP-1336635-B1 Polyhydroxyalkanoate having amide group and sulfonic group, method of producing the same, charge controlling agent containing the polyhydroxyalkanoate, toner binder, toner, and image formation method and image forming apparatus using the toner CANON KK (JP) 2007-01-17 EP disclosed
US-20060263432-A1 Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response CANON KABUSHIKI KAISHA (JP) 2006-11-23 US disclosed
CN-1285640-C Molecular weight control method of poly hydroxy alkane acid ester CANON KK (JP) 2006-11-22 CN disclosed
CN-1285639-C Polyhydroxy alkane acid ester, its preparing process, charge controling agent containing its, toner adhesive and toner and image forming method using said toner and forming device of image CANON KK (JP) 2006-11-22 CN disclosed
CN-1278675-C Granular material comprising polyhydroxyalkanoate and method for producing the same CANON KK (JP) 2006-10-11 CN disclosed
CN-1802610-A Polyhydroxyalkanoate containing amide group, sulfonic acid group and sulfonate group, method for producing the same, and charge control agent, toner, image forming method and image forming apparatus CANON KK (JP) 2006-07-12 CN disclosed
EP-1367078-A2 Method of producing polyhydroxyalkanoate from alkane having residue containing aromatic ring in its molecule CANON KABUSHIKI KAISHA (JP) 2003-12-03 EP disclosed
US-20030207412-A1 Method of producing polyhydroxyalkanoate from alkane having residue containing aromatic ring in its molecule CANON KABUSHIKI KAISHA (JP) 2003-11-06 US disclosed
CN-1440992-A Molecular weight control method of poly hydroxy alkane acid ester CANON KK (JP) 2003-09-10 CN disclosed
CN-1440991-A Polyhydroxy alkane acid ester, its preparing process, charge controling agent containing its, toner adhesive and toner and image forming method using said toner and forming device of image CANON KK (JP) 2003-09-10 CN disclosed
EP-1340777-A1 Novel polyhydroxyalkanoate, method of producing the same, charge controlling agent containing polyhydroxyalkanoate, toner binder and toner, and image formation method and image forming apparatus using toner CANON KABUSHIKI KAISHA (JP) 2003-09-03 EP disclosed
EP-1336635-A1 Polyhydroxyalkanoate having amide group and sulfonic group, method of producing the same, charge controlling agent containing the polyhydroxyalkanoate, toner binder, toner, and image formation method and image forming apparatus using the toner CANON KABUSHIKI KAISHA (JP) 2003-08-20 EP disclosed
CN-1431041-A Granular material comprising polyhydroxyalkanoate and method for producing the same CANON KK (JP) 2003-07-23 CN disclosed
US-20030073804-A1 Polyhydroxyalkanoate, producing method therefor charge control agent containing such polyhydroxyalkanoate, toner containing such charge control agent and image forming method and image forming apparatus utilizing such toner CANON KABUSHIKI KAISHA (JP) 2003-04-17 US disclosed
US-20020164726-A1 Polyhydroxyalkanoate and method of producing same, and w-(2-thienylsulfanyl) alkanoic acid and method of producing same CANON KABUSHIKI KAISHA (JP) 2002-11-07 US disclosed
EP-1236754-A2 Polyhydroxyalkanoate and method of producing same, and omega-(2-thienylsulfanyl) alkanoic acid and method of producing same CANON KABUSHIKI KAISHA (JP) 2002-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060263432-A1 Useful as a sustained release pharmaceutical preparation; microcapsule stably containing a drug, especially a water-soluble drug at high content and which has magnetic property; drug delivery; excellent in dispersibility and magnetic response SKP1, HAMP, AUP1 KMT2A 3735/4885SMN1; SMN2 3508/4885HPGD 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.